Investing Ideas
/
Australian Pharmaceuticals & Biotech Nano Cap Stocks

Header cover image

Australian Pharmaceuticals & Biotech Nano Cap Stocks

UPDATED Apr 16, 2024

Stocks with a market cap under US$50M.

11 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
	MVP Medical Developments International	AU$0.55	-10.6%	-48.1%	AU$47.5m	AU$3.03	PS1.4x	E66.5%	0%
	MVP Medical Developments International	AU$0.55	-9.8%	-47.6%	AU$47.5m	AU$3.03	PS1.4x	E66.5%	0%
	LGP Little Green Pharma	AU$0.14	-3.6%	-22.9%	AU$40.5m	n/a	PS1.7x	E46.0%	n/a
	CTE Cryosite	AU$0.70	9.4%	-4.1%	AU$34.2m	n/a	PE21.7x	n/a	2.1%
	CTE Cryosite	AU$0.65	0%	n/a	AU$34.2m	n/a	PE21.7x	n/a	2.1%
	BDX BCAL Diagnostics	AU$0.11	14.6%	n/a	AU$26.5m	n/a	PS7.1x	E60.0%	n/a
	BDX BCAL Diagnostics	AU$0.10	10.5%	43.8%	AU$26.5m	n/a	PS7.1x	E60.0%	n/a
	KZA Kazia Therapeutics	AU$0.08	-27.3%	-19.2%	AU$18.9m	n/a	PS34068.4x	E49.6%	n/a
	KZA Kazia Therapeutics	AU$0.08	-27.3%	-17.5%	AU$18.9m	n/a	PS34068.4x	E49.6%	n/a
	ACR Acrux	AU$0.06	-4.0%	12.0%	AU$18.0m	n/a	PS1.6x	E115.3%	0%
	ACR Acrux	AU$0.062	-1.6%	19.2%	AU$17.2m	n/a	PS1.6x	E115.3%	0%

Page 1 of 1